Johnson & Johnson (JNJ) stock dipped early Tuesday after the S&P 500 pharma giant reported adjusted income of $2.80 per share on nearly $24 billion in third-quarter sales.On average, analysts polled by FactSet expected J&J to earn $2.76 a share on $23.76 billion in sales. During the year-earlier period, Johnson & Johnson had $2.42 earnings per share and $22.47 billion in sales.The company also announced plans to separate its orthopedics business into a standalone company called DePuy Synthes. Following the ...

公司业绩与股价表现 - 公司公布超预期并上调指引的财报后 股价上涨并接近历史最高纪录 [1] - 公司宣布计划分拆其骨科业务 [1]

As we discussed previously , Continental AG( CTTAY completed its spinoff of AUMOVIO and shares began trading in Frankfurt today . AUMOVIO is an automotive behemoth with nearly 20 Billion Euro in annual sales. The company has no debt and 1.5 Billion Euro in cash. AUMOVIO hopes to increase its adjusted EBIT margin from 2.7% in the first half of 2025 to 6-8% while growing annual sales to 24 Billion Euro. If it is able to do so, shareholders should be richly rewarded.Continental shareholders received one share ...